After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, JANX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Janux Therapeutics Inc is $836.66M. A total of 1.23 million shares were traded on the day, compared to an average of 1.93M shares.
In the most recent transaction, Meyer Andrew Hollman sold 1,879 shares of JANX for 13.73 per share on Jan 02 ’26. After the transaction, the Chief Business Officer now owns 83,095 company shares. In a previous transaction on Jan 02 ’26, DiRaimondo Thomas sold 2,505 shares at 13.73 per share. JANX shares that Chief Scientific Officer owns now total 124,425.
Among the insiders who sold shares, Campbell David Alan disposed of 8,072 shares on Jan 02 ’26 at a per-share price of $13.73. This resulted in the President and CEO holding 284,982 shares of JANX after the transaction. In another insider transaction, Winter Charles M. sold 2,401 shares at $13.73 per share on Jan 02 ’26. Company shares held by the Chief Technical Officer now total 77,721.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, JANX has a high of $50.89 and a low of $13.26.
As of this writing, JANX has an earnings estimate of -$0.64 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.43 per share and a lower estimate of -$0.94. The company reported an EPS of -$0.36 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. JANX’s latest balance sheet shows that the firm has $374.96M in Cash & Short Term Investments as of fiscal 2021. There were $194.00k in debt and $12.80M in liabilities at the time. Its Book Value Per Share was $16.24, while its Total Shareholder’s Equity was $366.33M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
